# Biotrend’in net zararı 1 Ocak–30 Eylül 2026’da 171,5 milyon TL oldu - Bağlantı: https://www.borsatek.com/bioen-net-zarar-2026-9-ay/ - Yayımlanma: 2026-11-09T18:26:04+03:00 - Yazar: Haber Merkezi Reklam [ ⌊Stablex Kare Banner⌉ ](https://track.adform.net/C/?bn=91045298;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_50}) Biotrend (BIOEN), 1 Ocak–30 Eylül 2026 döneminde ana ortaklığa ait net zararı 171,5 milyon TL olarak kaydetti. Şirketten KAP’a gönderilen bildirime göre, bu dönemde hasılat 2.326.685.940 TL olurken satışların maliyeti 2.515.289.018 TL oldu ve ticari faaliyetlerden 188.603.078 TL brüt zarar yazıldı. Genel yönetim giderleri 584.298.985 TL, pazarlama giderleri 5.914.915 TL, esas faaliyetlerden diğer gelirler 53.758.109 TL ve diğer giderler 56.201.886 TL olarak gerçekleşti; esas faaliyet zararı 781.260.755 TL seviyesinde oluştu. Yatırım faaliyetlerinden 14.027.519 TL gelir ve 6.111.928 TL gider kaydedildi; özkaynak yöntemiyle değerlenen yatırımlardan 80.359.954 TL zarar payı oluştu. Finansman gelirleri 43.010.239 TL, finansman giderleri 1.131.370.948 TL oldu; enflasyon muhasebesi kapsamında net parasal pozisyon kazançları 1.446.940.477 TL yansıdı. Vergi öncesi zarar 495.125.350 TL seviyesinde gerçekleşirken 323.576.135 TL vergi geliri ile dönem net zararı 171.549.215 TL oldu. Bilanço tarafında toplam varlıklar 12.037.714.511 TL seviyesine ulaştı; özkaynaklar 3.119.565.444 TL olarak açıklandı. Finansal Tablolar ![Finansal Durum Tablosu (Bilanço)](https://i3.wp.com/www.borsatek.com/app/uploads/ 2026/11/kap-fin-1695471-t01.png) ![Kar veya Zarar Tablosu](https://i2.wp.com/www.borsatek.com/app/uploads/2026/11/ kap-fin-1695471-t02.png) ![Nakit Akış Tablosu](https://i3.wp.com/www.borsatek.com/app/uploads/2026/11/kap- fin-1695471-t03.png) ![Kar veya Zarar Tablosu](https://i1.wp.com/www.borsatek.com/app/uploads/2026/11/ kap-fin-1695471-t04.png) 📎 Bildirim Ekleri [📄BIOTREND SPK Konsolide Rapor – 30.09.2026.pdfPDF](https://www.borsatek.com/kap-git/?u=aHR0cHM6Ly93d3cua2FwLm9yZy50ci90ci9hcGkvZmlsZS9kb3dubG9hZC80MDI4MzI4Y2ExN2U0ZjVmMDFhMWMwOWE0NTRjNzIwZQ) Bildirim Eki Sayfaları ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 1](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p01.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 2](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p02.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 3](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p03.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 4](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p04.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 5](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p05.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 6](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p06.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 7](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p07.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 8](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p08.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 9](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p09.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 10](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p10.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 11](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p11.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 12](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p12.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 13](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p13.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 14](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p14.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 15](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p15.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 16](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p16.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 17](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p17.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 18](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p18.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 19](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p19.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 20](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p20.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 21](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p21.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 22](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p22.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 23](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p23.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 24](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p24.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 25](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p25.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 26](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p26.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 27](https://i2.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p27.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 28](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p28.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 29](https://i1.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p29.webp) ![BIOTREND SPK Konsolide Rapor - 30.09.2026.pdf — sayfa 30](https://i3.wp.com/www. borsatek.com/app/uploads/2026/11/kap-4028328ca17e4f5f01a1c09a454c720e-p30.webp)